Informed decision-making based on a leaflet in the context of prostate cancer screening.
Informed decision-making based on a leaflet in the context of prostate cancer screening.
复制标题
根据前列腺癌筛查背景下的传单做出明智的决策。
DOI：
10.1016/j.pec.2019.03.009
复制
发表时间：
2019
影响因子：
3.5
通讯作者：
deKoning,HarryJ
中科院分区：
文献类型：
--
作者：
Dierks,Tessa;Heijnsdijk,EvelineAM;Korfage,IdaJ;Roobol,MoniqueJ;deKoning,HarryJ
目的我们旨在评估男性在前列腺癌筛查中做出明智选择的程度，以及书面材料对这一过程的贡献。方法我们编制了一份描述前列腺癌筛查的传单，并编制了一份由知识、态度和意向筛查吸收成分组成的问卷，以评估知情决策。传单和问卷在目标人群的男性中进行了试点测试，进行了相应的调整，并发送给了一个在线研究小组的761名成员。结果有效率为66%(501/761)。阅读传单的组(n= 342)正确回答一项知识的次数(10.9%比8.8%；p<； 0.001)明显高于没有阅读传单的组(n= 159)，并做出了更明智的选择(73%比56%；p= 0.001)。两组在态度和筛查意向方面无显著差异。结论阅读过传单可能是提高知识水平和知情决策的因素之一。实践意义本研究结果表明，在前列腺癌筛查中增加知识和支持知情决策是可行的。
ObjectiveWe aimed to assess to what extent men make informed choices in the context of prostate cancer screening and how written material contributes to that process.MethodsWe developed a leaflet describing prostate cancer screening, and a questionnaire consisting of knowledge, attitude, and intended screening uptake components to assess informed decision-making. The leaflet and questionnaire were pilot-tested among men of the target population, adapted accordingly, and sent to 761 members of an online research panel. We operationalized whether the leaflet was read as spending one minute on the leaflet page and by a self-reported answer of respondents.ResultsThe response rate was 66% (501/761). The group who read the leaflet (n= 342) correctly answered a knowledge item significantly more often (10.9 versus 8.8;p< 0.001) than those who did not read the leaflet (n= 159), and made more informed choices (73% versus 56%;p= 0.001). There were no significant differences in attitude and intended screening uptake between both groups.ConclusionHaving read the leaflet could be one of the factors associated with increased levels of knowledge and informed decision-making.Practical implicationsThe results of this study showed that increasing knowledge and supporting informed decision-making with written material are feasible in prostate cancer screening.